Research findings last week included US vaccines maker Vaxcyte releasing highly impressive Phase III data for its VAX-31, for ...

Given the impact of the illegal medicines trade on public health in Latin America, on confidence in the health system and on ...

US biopharma company Mineralys Therapeutics today announced the presentation of a new analysis from its pivotal Phase III ...

Leading Swiss contract development and manufacturing organization (CDMO) Lonza and Onava, a US biotech building an AI-native ...

Data presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 showed that Eli Lilly’s ...

Belgo-Dutch immunology specialist argenx announced that it will discontinue the Phase III UNITY study of efgartigimod ...

Israel-based Teva Pharmaceutical Industries US subsidiary today revealed that the US Food and Drug Administration (FDA) has ...

India's pharmaceutical manufacturing industry is entering a delicate phase in its development. As uncertainty grows over its ...

Privately-held Endeavor BioMedicines said its Phase IIb WHISTLE-PF trial of taladegib (ENV-101) met its primary endpoint in ...

When the World Health Organization (WHO) updates its Model List of Essential Medicines (EML), it gives governments a ...

Belgian life sciences company SpectaCell has launched with 6 million euros ($6.7 million) in seed financing to develop a cell ...

US biotech Outlook Therapeutics, which is specializing in the development and commercialization of Lytenava (bevacizumab-vikg ...